Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity
Consenso español sobre la utilización de natalizumab (Tysabri®) - 2011
TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab
Therapeutic decisions in multiple sclerosis: moving beyond efficacy
